Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $8.94K | $731K | $616K | $456K |
| Revenue growth | — | 8083.2% | -15.8% | -26.0% |
| Gross profit | $4.85K | $432K | $380K | $250K |
| Gross margin | 54.3% | 59.0% | 61.7% | 54.9% |
| Operating income | -$1.99M | -$9.22M | -$7.97M | -$18.0M |
| Operating margin | -22279.7% | -1260.3% | -1294.4% | -3954.3% |
| Net income | -$2.00M | -$9.21M | -$8.71M | -$20.6M |
| Net margin | -22352.1% | -1259.4% | -1413.6% | -4526.8% |
| EPS (diluted) | -$0.19 | -$8.58 | -$4.80 | -$2.17 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$1.35M | -$7.00M | -$4.86M | -$5.85M |
| Capital expenditures | $43.1K | $3.52K | — | — |
| Free cash flow | -$1.39M | -$7.00M | — | — |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $683K | $739K | $58.7K | $1.49M |
| Total assets | $1.00M | $1.05M | $15.4M | $16.1M |
| Total liabilities | $389K | $276K | $1.43M | $891K |
| Shareholders' equity | $614K | $775K | $13.9M | $15.2M |
| Retained earnings | -$2.02M | -$11.2M | -$20.0M | -$40.6M |
| Shares (wtd avg diluted) | 10.8M | 1.07M | 1.98M | 10.1M |
Every figure is extracted from MANGOCEUTICALS, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.